For patients treated at the Centre Henri Becquerel, the per-therapeutic PET/CT was performed on a
Biograph Sensation 16 Hi-Rez device (Siemens Medical Solutions, Erlangen, Germany), without time of flight system or image reconstruction algorithm incorporating point-spread function. Forty-six patients underwent their PET/CT on this device. They were unrolled in S1–3 monocentric clinical trials (39 patients), and in S4 (7 patients). As the PET/CT device corresponded to an old generation model, these patients were grouped into a database called S
old.
Patients who underwent their FDG PET/CT on a new generation of positron-emission tomograph came from S4 study. All the image reconstruction algorithms incorporated a point-spread function, while some of them used a time of flight system (ToF). They were grouped into a database called S
New (21 patients). The PET/CT models and their characteristics are listed in
Appendix.
All 67 patients underwent a FDG PET/CT during the fifth week of radiation therapy. Protocols of acquisition and reconstruction followed EANM procedure guidelines [5 (
link)], but they were inherent to each nuclear medicine department. On the other hand, they were the same for a given device.
Ganem J., Thureau S., Gardin I., Modzelewski R., Hapdey S, & Vera P. (2018). Delineation of lung cancer with FDG PET/CT during radiation therapy. Radiation Oncology (London, England), 13, 219.